PE: How do global pharma growth strategies differ from domestic strategies? Ackerman: There are two different models for ...
Amanda Murphy, Senior Director at GlobalData, discusses how real-time intelligence can turns regulatory events into opportunities.
An advocate for women’s reproductive health, she started one of the world’s smallest pharmaceutical companies to bring an ...
ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), ...
Under the plan, the company will dissolve and its owners, members of the Sackler family, will pay as much as $7 billion of ...
Medpage Today on MSN
Does Microdosing GLP-1s Work? Expert Weighs In
For standard GLP-1 usage, Roslin said that patients are started with a low dose and titrated up to clinical effect. That ...
The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month ...
Creating revolutionary pharmaceutical drugs, testing new materials for cars and simulating how market scenarios can affect banks — these are just some of the tasks that could take months or years to ...
StockStory.org on MSN
Why Are Collegium Pharmaceutical (COLL) Shares Soaring Today
What Happened? Shares of pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) jumped 11.6% in the morning session ...
6don MSN
The White House knows it needs to act on health care affordability. Here’s what’s on the table.
Senior Trump administration health officials have been meeting to discuss how to respond to the year-end ACA subsidy ...
The obligations and responsibilities of governments and drug companies to increase access to costly new drugs should be grounded in international human rights, write Trudo Lemmens and colleagues ...
The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback